

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 4.73837238 |
| 2 | plasma membrane repair (GO:0001778) | 4.27904753 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.21526057 |
| 4 | skin morphogenesis (GO:0043589) | 4.19698392 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 4.10776663 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 4.10776663 |
| 7 | fatty acid transmembrane transport (GO:1902001) | 4.03173260 |
| 8 | carnitine shuttle (GO:0006853) | 4.01792210 |
| 9 | type B pancreatic cell proliferation (GO:0044342) | 3.90403342 |
| 10 | regulation of sequestering of triglyceride (GO:0010889) | 3.88552503 |
| 11 | protein retention in ER lumen (GO:0006621) | 3.87977684 |
| 12 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.87279886 |
| 13 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.85868931 |
| 14 | virion attachment to host cell (GO:0019062) | 3.85523121 |
| 15 | adhesion of symbiont to host cell (GO:0044650) | 3.85523121 |
| 16 | sarcomere organization (GO:0045214) | 3.84759829 |
| 17 | barbed-end actin filament capping (GO:0051016) | 3.84035607 |
| 18 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.69872747 |
| 19 | adhesion of symbiont to host (GO:0044406) | 3.69160720 |
| 20 | basement membrane organization (GO:0071711) | 3.65073077 |
| 21 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.62028155 |
| 22 | tricarboxylic acid cycle (GO:0006099) | 3.58180701 |
| 23 | protein localization to endosome (GO:0036010) | 3.52949617 |
| 24 | epithelial cell-cell adhesion (GO:0090136) | 3.52759811 |
| 25 | apoptotic cell clearance (GO:0043277) | 3.52187674 |
| 26 | fatty acid beta-oxidation (GO:0006635) | 3.39910578 |
| 27 | extracellular fibril organization (GO:0043206) | 3.37253778 |
| 28 | regulation of fatty acid oxidation (GO:0046320) | 3.36153237 |
| 29 | renal filtration (GO:0097205) | 3.35914071 |
| 30 | valine metabolic process (GO:0006573) | 3.33857877 |
| 31 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.28352505 |
| 32 | glomerular basement membrane development (GO:0032836) | 3.25568854 |
| 33 | semaphorin-plexin signaling pathway (GO:0071526) | 3.21451876 |
| 34 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.21146100 |
| 35 | positive regulation of fatty acid oxidation (GO:0046321) | 3.20738310 |
| 36 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.20030400 |
| 37 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.19027951 |
| 38 | regulation of tight junction assembly (GO:2000810) | 3.18629868 |
| 39 | carnitine transmembrane transport (GO:1902603) | 3.16645565 |
| 40 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.14961151 |
| 41 | cell adhesion mediated by integrin (GO:0033627) | 3.14110149 |
| 42 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13140515 |
| 43 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.09800127 |
| 44 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.09730162 |
| 45 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.09599245 |
| 46 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.08169720 |
| 47 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.07888201 |
| 48 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.07661888 |
| 49 | regulation of cholesterol storage (GO:0010885) | 3.07484144 |
| 50 | lysine metabolic process (GO:0006553) | 3.06191835 |
| 51 | lysine catabolic process (GO:0006554) | 3.06191835 |
| 52 | tricarboxylic acid metabolic process (GO:0072350) | 3.06071213 |
| 53 | carnitine transport (GO:0015879) | 3.05880534 |
| 54 | amino-acid betaine transport (GO:0015838) | 3.05880534 |
| 55 | collagen metabolic process (GO:0032963) | 3.04249399 |
| 56 | regulation of early endosome to late endosome transport (GO:2000641) | 3.03865009 |
| 57 | focal adhesion assembly (GO:0048041) | 3.02881753 |
| 58 | cell-substrate adherens junction assembly (GO:0007045) | 3.02881753 |
| 59 | lipid particle organization (GO:0034389) | 3.01821497 |
| 60 | substrate-dependent cell migration (GO:0006929) | 3.01582666 |
| 61 | fibril organization (GO:0097435) | 3.01061485 |
| 62 | cardiac myofibril assembly (GO:0055003) | 2.99737325 |
| 63 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.99511769 |
| 64 | endothelial cell chemotaxis (GO:0035767) | 2.99498504 |
| 65 | positive regulation of p38MAPK cascade (GO:1900745) | 2.98084997 |
| 66 | extracellular matrix disassembly (GO:0022617) | 2.96050142 |
| 67 | fatty acid oxidation (GO:0019395) | 2.95356902 |
| 68 | muscle filament sliding (GO:0030049) | 2.95175640 |
| 69 | actin-myosin filament sliding (GO:0033275) | 2.95175640 |
| 70 | * hemidesmosome assembly (GO:0031581) | 2.94948042 |
| 71 | extracellular matrix assembly (GO:0085029) | 2.94589361 |
| 72 | protein heterotrimerization (GO:0070208) | 2.94352257 |
| 73 | positive regulation of receptor recycling (GO:0001921) | 2.93395657 |
| 74 | chondrocyte proliferation (GO:0035988) | 2.92043541 |
| 75 | cell migration involved in heart development (GO:0060973) | 2.91289554 |
| 76 | * cell-substrate junction assembly (GO:0007044) | 2.89852604 |
| 77 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.89532914 |
| 78 | lipid oxidation (GO:0034440) | 2.89256963 |
| 79 | alpha-linolenic acid metabolic process (GO:0036109) | 2.88035445 |
| 80 | NADH metabolic process (GO:0006734) | 2.87940816 |
| 81 | regulation of skeletal muscle contraction (GO:0014819) | 2.86883737 |
| 82 | collagen catabolic process (GO:0030574) | 2.86318944 |
| 83 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.84149279 |
| 84 | regulation of p38MAPK cascade (GO:1900744) | 2.83326078 |
| 85 | brown fat cell differentiation (GO:0050873) | 2.83178793 |
| 86 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.83158210 |
| 87 | biotin metabolic process (GO:0006768) | 2.83089260 |
| 88 | regulation of extracellular matrix disassembly (GO:0010715) | 2.83067506 |
| 89 | glomerular filtration (GO:0003094) | 2.81748358 |
| 90 | positive regulation of osteoblast proliferation (GO:0033690) | 2.81004558 |
| 91 | fatty acid catabolic process (GO:0009062) | 2.80961528 |
| 92 | kidney mesenchyme development (GO:0072074) | 2.79981080 |
| 93 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.78417501 |
| 94 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.78312063 |
| 95 | wound healing, spreading of epidermal cells (GO:0035313) | 2.76814352 |
| 96 | 4-hydroxyproline metabolic process (GO:0019471) | 2.75719027 |
| 97 | multicellular organismal metabolic process (GO:0044236) | 2.75619183 |
| 98 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.75255973 |
| 99 | stress fiber assembly (GO:0043149) | 2.72975031 |
| 100 | negative regulation of cell size (GO:0045792) | 2.72682408 |
| 101 | hyaluronan catabolic process (GO:0030214) | 2.72490164 |
| 102 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.71965454 |
| 103 | muscle cell migration (GO:0014812) | 2.71842233 |
| 104 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.70281510 |
| 105 | cellular response to vitamin D (GO:0071305) | 2.69749558 |
| 106 | multicellular organismal catabolic process (GO:0044243) | 2.69008018 |
| 107 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.68954278 |
| 108 | mesodermal cell differentiation (GO:0048333) | 2.68325246 |
| 109 | intracellular lipid transport (GO:0032365) | 2.68189244 |
| 110 | heart trabecula formation (GO:0060347) | 2.67597771 |
| 111 | endothelial cell morphogenesis (GO:0001886) | 2.67298052 |
| 112 | triglyceride catabolic process (GO:0019433) | 2.67186607 |
| 113 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.66886064 |
| 114 | atrioventricular valve morphogenesis (GO:0003181) | 2.66217835 |
| 115 | actin filament depolymerization (GO:0030042) | 2.66108717 |
| 116 | hypotonic response (GO:0006971) | 2.65695322 |
| 117 | fibroblast migration (GO:0010761) | 2.64952620 |
| 118 | bone trabecula formation (GO:0060346) | 2.63630958 |
| 119 | endodermal cell differentiation (GO:0035987) | 2.62660760 |
| 120 | endocardial cushion development (GO:0003197) | 2.60838794 |
| 121 | * extracellular matrix organization (GO:0030198) | 2.60536943 |
| 122 | actomyosin structure organization (GO:0031032) | 2.59962123 |
| 123 | regulation of plasminogen activation (GO:0010755) | 2.59447960 |
| 124 | * extracellular structure organization (GO:0043062) | 2.59355786 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 2.58956764 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 2.57971850 |
| 127 | desmosome organization (GO:0002934) | 2.57244312 |
| 128 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.57215856 |
| 129 | actin-mediated cell contraction (GO:0070252) | 2.56999662 |
| 130 | cellular response to nutrient (GO:0031670) | 2.56634157 |
| 131 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.56093442 |
| 132 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.55431306 |
| 133 | glial cell migration (GO:0008347) | 2.55364393 |
| 134 | white fat cell differentiation (GO:0050872) | 2.54919571 |
| 135 | wound healing, spreading of cells (GO:0044319) | 2.54420535 |
| 136 | adherens junction assembly (GO:0034333) | 2.53522206 |
| 137 | blood vessel endothelial cell migration (GO:0043534) | 2.53361058 |
| 138 | regulation of glomerular filtration (GO:0003093) | 2.52702120 |
| 139 | endocytic recycling (GO:0032456) | 2.52166174 |
| 140 | protein hydroxylation (GO:0018126) | 2.51707665 |
| 141 | protein maturation by protein folding (GO:0022417) | 2.51589546 |
| 142 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.50928948 |
| 143 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.50347376 |
| 144 | venous blood vessel morphogenesis (GO:0048845) | 2.50170343 |
| 145 | glomerular visceral epithelial cell development (GO:0072015) | 2.50107472 |
| 146 | cardiac muscle cell development (GO:0055013) | 2.49792648 |
| 147 | negative regulation of cartilage development (GO:0061037) | 2.49655073 |
| 148 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.49264268 |
| 149 | growth hormone receptor signaling pathway (GO:0060396) | 2.48912076 |
| 150 | myofibril assembly (GO:0030239) | 2.48350844 |
| 151 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48282877 |
| 152 | regulation of cardioblast differentiation (GO:0051890) | 2.47719223 |
| 153 | quaternary ammonium group transport (GO:0015697) | 2.47438937 |
| 154 | peptidyl-proline hydroxylation (GO:0019511) | 2.46996821 |
| 155 | protein carboxylation (GO:0018214) | 2.46788665 |
| 156 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.46788665 |
| 157 | collagen fibril organization (GO:0030199) | 2.46071065 |
| 158 | negative regulation of fatty acid transport (GO:2000192) | 2.45952440 |
| 159 | positive regulation of lipid storage (GO:0010884) | 2.43991737 |
| 160 | UV protection (GO:0009650) | 2.43672459 |
| 161 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.43496808 |
| 162 | epoxygenase P450 pathway (GO:0019373) | 2.42439804 |
| 163 | actin filament bundle assembly (GO:0051017) | 2.42288486 |
| 164 | actin filament bundle organization (GO:0061572) | 2.42288486 |
| 165 | surfactant homeostasis (GO:0043129) | 2.41892326 |
| 166 | cellular response to growth hormone stimulus (GO:0071378) | 2.41588693 |
| 167 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.40384665 |
| 168 | cardiac cell development (GO:0055006) | 2.39410814 |
| 169 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.39257660 |
| 170 | transcytosis (GO:0045056) | 2.38846819 |
| 171 | neutral lipid catabolic process (GO:0046461) | 2.38674228 |
| 172 | acylglycerol catabolic process (GO:0046464) | 2.38674228 |
| 173 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.38558140 |
| 174 | cellular response to vitamin (GO:0071295) | 2.38409571 |
| 175 | branched-chain amino acid metabolic process (GO:0009081) | 2.37937615 |
| 176 | pentose-phosphate shunt (GO:0006098) | 2.37151611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.88245091 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.29210176 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.23527064 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.77413759 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.54331525 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.50473329 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.46281596 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.84545696 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56534344 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.55203838 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.52175199 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.40165110 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.33533372 |
| 14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.23428309 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.21102268 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20929655 |
| 17 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.05614518 |
| 18 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.92176458 |
| 19 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.89242343 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.88792099 |
| 21 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.86850631 |
| 22 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.86850631 |
| 23 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.82128987 |
| 24 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.82121414 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.74806852 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73380771 |
| 27 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.72891655 |
| 28 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.71287631 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64381575 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63931172 |
| 31 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.62591473 |
| 32 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.61043343 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60703974 |
| 34 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.57394312 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56789298 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54332145 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51596860 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48095710 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44500654 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.43358621 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42488831 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41966591 |
| 43 | CJUN_26792858_Chip-Seq_BT549_Human | 1.40838444 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.40727568 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.40226941 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39207462 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38880582 |
| 48 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.38242403 |
| 49 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37207073 |
| 50 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37207073 |
| 51 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.35884879 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35469117 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35147710 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33339829 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32851933 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29368796 |
| 57 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.28442446 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27181441 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26839437 |
| 60 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26580308 |
| 61 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26471849 |
| 62 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26294374 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.26266794 |
| 64 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24777751 |
| 65 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23388655 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21458027 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21423998 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21199228 |
| 69 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20061711 |
| 70 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19591379 |
| 71 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18519380 |
| 72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18159609 |
| 73 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18109227 |
| 74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17911416 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.17894412 |
| 76 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17738078 |
| 77 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.16964078 |
| 78 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15603262 |
| 79 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15276356 |
| 80 | P68_20966046_ChIP-Seq_HELA_Human | 1.15044007 |
| 81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13536857 |
| 82 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.13386164 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13047563 |
| 84 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11238753 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10574885 |
| 86 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.08539212 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08335319 |
| 88 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07416861 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06881582 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06712411 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05930001 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05629685 |
| 93 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.05309677 |
| 94 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04129440 |
| 95 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03590599 |
| 96 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03521877 |
| 97 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03217180 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02232425 |
| 99 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01435415 |
| 100 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00887913 |
| 101 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00061272 |
| 102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99505477 |
| 103 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99221160 |
| 104 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99085005 |
| 105 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97488745 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97402888 |
| 107 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97116135 |
| 108 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95811170 |
| 109 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95456964 |
| 110 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95271283 |
| 111 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.94788617 |
| 112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94739926 |
| 113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94615859 |
| 114 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.94527410 |
| 115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93919838 |
| 116 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92309930 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91951047 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91804930 |
| 119 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.91797118 |
| 120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91598333 |
| 121 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90789949 |
| 122 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.89598974 |
| 123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88760696 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88182791 |
| 125 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85546953 |
| 126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84030518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.01572322 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.59085757 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.20398671 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.19847671 |
| 5 | MP0004272_abnormal_basement_membrane | 2.92454243 |
| 6 | MP0005257_abnormal_intraocular_pressure | 2.90949614 |
| 7 | MP0005275_abnormal_skin_tensile | 2.80606835 |
| 8 | MP0005670_abnormal_white_adipose | 2.79933321 |
| 9 | MP0004130_abnormal_muscle_cell | 2.63044058 |
| 10 | MP0000751_myopathy | 2.62164954 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.38657291 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.33437211 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.15649368 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.14148934 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.12490521 |
| 16 | MP0003279_aneurysm | 2.03216382 |
| 17 | MP0010030_abnormal_orbit_morphology | 2.00852894 |
| 18 | MP0005330_cardiomyopathy | 1.99038949 |
| 19 | MP0001958_emphysema | 1.97929674 |
| 20 | MP0000749_muscle_degeneration | 1.94824794 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.92275480 |
| 22 | MP0004087_abnormal_muscle_fiber | 1.92062024 |
| 23 | MP0006138_congestive_heart_failure | 1.86156764 |
| 24 | MP0005375_adipose_tissue_phenotype | 1.77913934 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.77525049 |
| 26 | MP0005623_abnormal_meninges_morphology | 1.72880305 |
| 27 | MP0003646_muscle_fatigue | 1.72043452 |
| 28 | MP0001542_abnormal_bone_strength | 1.70583718 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.69198976 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.60883351 |
| 31 | MP0001544_abnormal_cardiovascular_syste | 1.59776257 |
| 32 | MP0005385_cardiovascular_system_phenoty | 1.59776257 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.59319519 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.54347889 |
| 35 | MP0005508_abnormal_skeleton_morphology | 1.49632898 |
| 36 | MP0002269_muscular_atrophy | 1.46874602 |
| 37 | MP0003828_pulmonary_edema | 1.45115108 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.44062806 |
| 39 | MP0005620_abnormal_muscle_contractility | 1.43930188 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.43295403 |
| 41 | MP0005409_darkened_coat_color | 1.39813116 |
| 42 | MP0009384_cardiac_valve_regurgitation | 1.38880755 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.35298376 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.32116087 |
| 45 | MP0005023_abnormal_wound_healing | 1.29889725 |
| 46 | MP0005595_abnormal_vascular_smooth | 1.28563891 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.28469071 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.28110782 |
| 49 | MP0000747_muscle_weakness | 1.28095978 |
| 50 | MP0009053_abnormal_anal_canal | 1.27800095 |
| 51 | MP0000343_altered_response_to | 1.26881961 |
| 52 | MP0000762_abnormal_tongue_morphology | 1.26778479 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.26546855 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.24984743 |
| 55 | MP0005503_abnormal_tendon_morphology | 1.23766452 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.23472264 |
| 57 | MP0003941_abnormal_skin_development | 1.22149361 |
| 58 | MP0000733_abnormal_muscle_development | 1.19210382 |
| 59 | MP0005360_urolithiasis | 1.16722123 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.16680391 |
| 61 | MP0000467_abnormal_esophagus_morphology | 1.16205082 |
| 62 | MP0006054_spinal_hemorrhage | 1.15722736 |
| 63 | MP0004484_altered_response_of | 1.15283361 |
| 64 | MP0000858_altered_metastatic_potential | 1.15082150 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.14368108 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.14333393 |
| 67 | MP0009840_abnormal_foam_cell | 1.13953631 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 1.13112186 |
| 69 | MP0002060_abnormal_skin_morphology | 1.12167015 |
| 70 | MP0002106_abnormal_muscle_physiology | 1.11862865 |
| 71 | MP0004233_abnormal_muscle_weight | 1.11116514 |
| 72 | MP0001243_abnormal_dermal_layer | 1.10587502 |
| 73 | MP0003045_fibrosis | 1.09831311 |
| 74 | MP0002971_abnormal_brown_adipose | 1.06391171 |
| 75 | MP0002295_abnormal_pulmonary_circulatio | 1.03676955 |
| 76 | MP0001756_abnormal_urination | 1.02661116 |
| 77 | MP0004858_abnormal_nervous_system | 1.02097920 |
| 78 | MP0005451_abnormal_body_composition | 1.01701602 |
| 79 | MP0005501_abnormal_skin_physiology | 1.00770032 |
| 80 | MP0003950_abnormal_plasma_membrane | 0.99928161 |
| 81 | MP0005165_increased_susceptibility_to | 0.98959053 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98014794 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.96741390 |
| 84 | MP0005369_muscle_phenotype | 0.95238689 |
| 85 | MP0002796_impaired_skin_barrier | 0.94142489 |
| 86 | MP0005390_skeleton_phenotype | 0.93858440 |
| 87 | * MP0009643_abnormal_urine_homeostasis | 0.93568686 |
| 88 | MP0009115_abnormal_fat_cell | 0.93458995 |
| 89 | MP0003329_amyloid_beta_deposits | 0.93451120 |
| 90 | * MP0003091_abnormal_cell_migration | 0.91832270 |
| 91 | MP0002128_abnormal_blood_circulation | 0.91684409 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.91567088 |
| 93 | MP0002933_joint_inflammation | 0.90652430 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.90611721 |
| 95 | MP0005332_abnormal_amino_acid | 0.90299142 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.90095686 |
| 97 | MP0004510_myositis | 0.90006497 |
| 98 | MP0005083_abnormal_biliary_tract | 0.89956627 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.89686311 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.89621016 |
| 101 | MP0005164_abnormal_response_to | 0.88684770 |
| 102 | MP0005365_abnormal_bile_salt | 0.87747719 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.86621512 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.85383594 |
| 105 | MP0005197_abnormal_uvea_morphology | 0.83973182 |
| 106 | MP0000537_abnormal_urethra_morphology | 0.83651941 |
| 107 | MP0002168_other_aberrant_phenotype | 0.83289270 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.83201600 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.83178024 |
| 110 | MP0003186_abnormal_redox_activity | 0.82685503 |
| 111 | MP0000579_abnormal_nail_morphology | 0.82048218 |
| 112 | MP0002108_abnormal_muscle_morphology | 0.81798426 |
| 113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81785836 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.80010385 |
| 115 | MP0001661_extended_life_span | 0.79702138 |
| 116 | MP0000266_abnormal_heart_morphology | 0.79333026 |
| 117 | MP0000163_abnormal_cartilage_morphology | 0.79024711 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.77814578 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.77650597 |
| 120 | MP0001849_ear_inflammation | 0.76494018 |
| 121 | MP0000609_abnormal_liver_physiology | 0.76490947 |
| 122 | MP0010771_integument_phenotype | 0.75929276 |
| 123 | MP0003448_altered_tumor_morphology | 0.74975858 |
| 124 | * MP0001614_abnormal_blood_vessel | 0.74907386 |
| 125 | MP0003252_abnormal_bile_duct | 0.73919121 |
| 126 | MP0003942_abnormal_urinary_system | 0.73415421 |
| 127 | MP0005334_abnormal_fat_pad | 0.72915507 |
| 128 | MP0000462_abnormal_digestive_system | 0.71466879 |
| 129 | MP0002254_reproductive_system_inflammat | 0.70245502 |
| 130 | MP0003385_abnormal_body_wall | 0.70009558 |
| 131 | MP0002113_abnormal_skeleton_development | 0.69751033 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.69464886 |
| 133 | MP0000534_abnormal_ureter_morphology | 0.69090872 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.69053882 |
| 135 | MP0002970_abnormal_white_adipose | 0.68731447 |
| 136 | MP0009250_abnormal_appendicular_skeleto | 0.68723122 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.68288851 |
| 138 | MP0005085_abnormal_gallbladder_physiolo | 0.67734634 |
| 139 | MP0008961_abnormal_basal_metabolism | 0.66724366 |
| 140 | MP0003283_abnormal_digestive_organ | 0.66504505 |
| 141 | MP0008260_abnormal_autophagy | 0.65989618 |
| 142 | MP0001533_abnormal_skeleton_physiology | 0.64690239 |
| 143 | * MP0000249_abnormal_blood_vessel | 0.64390791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 4.62600157 |
| 2 | Increased connective tissue (HP:0009025) | 4.39061725 |
| 3 | Muscle fiber splitting (HP:0003555) | 4.07002702 |
| 4 | Hyporeflexia of lower limbs (HP:0002600) | 4.06781696 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.93841229 |
| 6 | Premature rupture of membranes (HP:0001788) | 3.81721705 |
| 7 | Vertebral compression fractures (HP:0002953) | 3.68481032 |
| 8 | Ventricular tachycardia (HP:0004756) | 3.57241085 |
| 9 | Vascular tortuosity (HP:0004948) | 3.54716098 |
| 10 | Sudden death (HP:0001699) | 3.48931298 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.47701992 |
| 12 | Arterial tortuosity (HP:0005116) | 3.34291446 |
| 13 | Ankle contracture (HP:0006466) | 3.28918496 |
| 14 | Difficulty running (HP:0009046) | 3.23443405 |
| 15 | Myoglobinuria (HP:0002913) | 3.19859432 |
| 16 | Wormian bones (HP:0002645) | 3.16909652 |
| 17 | Broad metatarsal (HP:0001783) | 3.12212673 |
| 18 | Difficulty climbing stairs (HP:0003551) | 3.12040629 |
| 19 | Aortic aneurysm (HP:0004942) | 3.06708816 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 2.98705872 |
| 21 | Lipoatrophy (HP:0100578) | 2.98275313 |
| 22 | Abnormality of dentin (HP:0010299) | 2.96069369 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 2.92657407 |
| 24 | Spinal rigidity (HP:0003306) | 2.84690025 |
| 25 | Mesangial abnormality (HP:0001966) | 2.82137875 |
| 26 | Follicular hyperkeratosis (HP:0007502) | 2.76901521 |
| 27 | Aortic dissection (HP:0002647) | 2.75146637 |
| 28 | Increased variability in muscle fiber diameter (HP:0003557) | 2.74444534 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 2.74279821 |
| 30 | Atrophic scars (HP:0001075) | 2.72588017 |
| 31 | Distal lower limb amyotrophy (HP:0008944) | 2.68092986 |
| 32 | Shallow orbits (HP:0000586) | 2.63024703 |
| 33 | Ulnar bowing (HP:0003031) | 2.62561172 |
| 34 | Aneurysm (HP:0002617) | 2.59436335 |
| 35 | Palpitations (HP:0001962) | 2.57425761 |
| 36 | Mitral regurgitation (HP:0001653) | 2.56568007 |
| 37 | Hyperacusis (HP:0010780) | 2.55135059 |
| 38 | Distal lower limb muscle weakness (HP:0009053) | 2.53323511 |
| 39 | Myotonia (HP:0002486) | 2.51923998 |
| 40 | Joint stiffness (HP:0001387) | 2.51758032 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51046818 |
| 42 | Elbow flexion contracture (HP:0002987) | 2.46827450 |
| 43 | Acanthosis nigricans (HP:0000956) | 2.46775267 |
| 44 | Genu recurvatum (HP:0002816) | 2.46693850 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.46537380 |
| 46 | EMG: myopathic abnormalities (HP:0003458) | 2.44577659 |
| 47 | Exercise-induced myalgia (HP:0003738) | 2.43568079 |
| 48 | Lymphangioma (HP:0100764) | 2.42585563 |
| 49 | Abnormality of the calf musculature (HP:0001430) | 2.40748516 |
| 50 | Thin bony cortex (HP:0002753) | 2.39729466 |
| 51 | Biconcave vertebral bodies (HP:0004586) | 2.38621649 |
| 52 | Broad face (HP:0000283) | 2.38244305 |
| 53 | Facial diplegia (HP:0001349) | 2.35875269 |
| 54 | Neonatal short-limb short stature (HP:0008921) | 2.35672351 |
| 55 | Scapular winging (HP:0003691) | 2.32060719 |
| 56 | Cervical subluxation (HP:0003308) | 2.30988957 |
| 57 | Abnormality of the Achilles tendon (HP:0005109) | 2.30774894 |
| 58 | Atrial fibrillation (HP:0005110) | 2.30660928 |
| 59 | Aortic regurgitation (HP:0001659) | 2.30611819 |
| 60 | Calf muscle hypertrophy (HP:0008981) | 2.27759819 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.26445527 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.26445527 |
| 63 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.25905051 |
| 64 | Natal tooth (HP:0000695) | 2.24671597 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.23939451 |
| 66 | Fragile skin (HP:0001030) | 2.22306089 |
| 67 | Coxa vara (HP:0002812) | 2.21919522 |
| 68 | Dilated cardiomyopathy (HP:0001644) | 2.21673582 |
| 69 | Polycythemia (HP:0001901) | 2.20204155 |
| 70 | Spondylolisthesis (HP:0003302) | 2.19876486 |
| 71 | Joint laxity (HP:0001388) | 2.17305842 |
| 72 | Mitral stenosis (HP:0001718) | 2.16259641 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.16223816 |
| 74 | Abnormality of the acetabulum (HP:0003170) | 2.16012084 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.15916756 |
| 76 | Primary atrial arrhythmia (HP:0001692) | 2.15755122 |
| 77 | Hyperextensible skin (HP:0000974) | 2.15710796 |
| 78 | Supraventricular arrhythmia (HP:0005115) | 2.15665882 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.15637858 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.15637858 |
| 81 | Hyperglycinuria (HP:0003108) | 2.14740194 |
| 82 | Slender build (HP:0001533) | 2.13917066 |
| 83 | Peritonitis (HP:0002586) | 2.12048410 |
| 84 | Rectal prolapse (HP:0002035) | 2.11120223 |
| 85 | Disproportionate tall stature (HP:0001519) | 2.11054750 |
| 86 | Hypoalphalipoproteinemia (HP:0003233) | 2.10263158 |
| 87 | Wrist flexion contracture (HP:0001239) | 2.08468611 |
| 88 | Atrioventricular block (HP:0001678) | 2.08084668 |
| 89 | Muscle stiffness (HP:0003552) | 2.06154660 |
| 90 | Hand muscle atrophy (HP:0009130) | 2.05532970 |
| 91 | Bundle branch block (HP:0011710) | 2.05276157 |
| 92 | Supraventricular tachycardia (HP:0004755) | 2.04655656 |
| 93 | Limb-girdle muscle atrophy (HP:0003797) | 2.02341935 |
| 94 | Dysostosis multiplex (HP:0000943) | 2.00473331 |
| 95 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.99387363 |
| 96 | Bowel diverticulosis (HP:0005222) | 1.99143512 |
| 97 | Abnormal delivery (HP:0001787) | 1.98431494 |
| 98 | Back pain (HP:0003418) | 1.97999114 |
| 99 | Bowed forearm bones (HP:0003956) | 1.97723648 |
| 100 | Bowing of the arm (HP:0006488) | 1.97723648 |
| 101 | Osteolytic defects of the hand bones (HP:0009699) | 1.97433160 |
| 102 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97433160 |
| 103 | Multiple enchondromatosis (HP:0005701) | 1.97394553 |
| 104 | Long toe (HP:0010511) | 1.95792111 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 1.95477796 |
| 106 | Mucopolysacchariduria (HP:0008155) | 1.94544905 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94544905 |
| 108 | Ketoacidosis (HP:0001993) | 1.94047865 |
| 109 | Abnormal atrioventricular conduction (HP:0005150) | 1.93625783 |
| 110 | Mitral valve prolapse (HP:0001634) | 1.92766106 |
| 111 | Aortic valve stenosis (HP:0001650) | 1.92164980 |
| 112 | Dilatation of the ascending aorta (HP:0005111) | 1.91828792 |
| 113 | Oligomenorrhea (HP:0000876) | 1.91624368 |
| 114 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.91556561 |
| 115 | Conjunctival hamartoma (HP:0100780) | 1.90572596 |
| 116 | Ventricular arrhythmia (HP:0004308) | 1.90224897 |
| 117 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88630902 |
| 118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88630902 |
| 119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88630902 |
| 120 | Xanthomatosis (HP:0000991) | 1.88215661 |
| 121 | Focal segmental glomerulosclerosis (HP:0000097) | 1.87775875 |
| 122 | Distal arthrogryposis (HP:0005684) | 1.86773479 |
| 123 | Enlarged penis (HP:0000040) | 1.84908863 |
| 124 | Stridor (HP:0010307) | 1.83736516 |
| 125 | Nuclear cataract (HP:0100018) | 1.82247644 |
| 126 | Knee flexion contracture (HP:0006380) | 1.82221443 |
| 127 | Hematochezia (HP:0002573) | 1.82105544 |
| 128 | Lower limb amyotrophy (HP:0007210) | 1.81467216 |
| 129 | Hyperammonemia (HP:0001987) | 1.80975584 |
| 130 | Ovoid vertebral bodies (HP:0003300) | 1.80870818 |
| 131 | Ectopia lentis (HP:0001083) | 1.80704450 |
| 132 | Deep venous thrombosis (HP:0002625) | 1.80496096 |
| 133 | Congenital glaucoma (HP:0001087) | 1.80003805 |
| 134 | Syncope (HP:0001279) | 1.79790035 |
| 135 | Abnormal ossification of hand bones (HP:0005921) | 1.79752849 |
| 136 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.79094019 |
| 137 | Abnormality of carpal bone ossification (HP:0006257) | 1.78618031 |
| 138 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78543911 |
| 139 | Generalized amyotrophy (HP:0003700) | 1.78499366 |
| 140 | Hemorrhage of the eye (HP:0011885) | 1.78476549 |
| 141 | Testicular atrophy (HP:0000029) | 1.78164150 |
| 142 | Hypoventilation (HP:0002791) | 1.77856900 |
| 143 | Heart block (HP:0012722) | 1.77315923 |
| 144 | Flat acetabular roof (HP:0003180) | 1.76780749 |
| 145 | Myocardial infarction (HP:0001658) | 1.76679494 |
| 146 | Bladder diverticulum (HP:0000015) | 1.76249978 |
| 147 | Esophageal varix (HP:0002040) | 1.76160552 |
| 148 | Achilles tendon contracture (HP:0001771) | 1.75662143 |
| 149 | Short nail (HP:0001799) | 1.75033859 |
| 150 | Spinal cord compression (HP:0002176) | 1.74740984 |
| 151 | Soft skin (HP:0000977) | 1.74401034 |
| 152 | Hypertriglyceridemia (HP:0002155) | 1.73618507 |
| 153 | Axonal loss (HP:0003447) | 1.73240344 |
| 154 | Blue sclerae (HP:0000592) | 1.72683290 |
| 155 | Abnormality of glycine metabolism (HP:0010895) | 1.72675348 |
| 156 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.72675348 |
| 157 | J-shaped sella turcica (HP:0002680) | 1.72530397 |
| 158 | Ketosis (HP:0001946) | 1.72354547 |
| 159 | Round ear (HP:0100830) | 1.72028255 |
| 160 | Muscle fiber inclusion bodies (HP:0100299) | 1.72025837 |
| 161 | Vascular calcification (HP:0004934) | 1.70399841 |
| 162 | Nonimmune hydrops fetalis (HP:0001790) | 1.70163299 |
| 163 | Bradycardia (HP:0001662) | 1.69125830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.86437805 |
| 2 | TTN | 4.24547345 |
| 3 | PKN2 | 3.09528615 |
| 4 | LMTK2 | 2.64849117 |
| 5 | IRAK3 | 2.59662755 |
| 6 | ERN1 | 2.48562869 |
| 7 | BCKDK | 2.31108590 |
| 8 | TIE1 | 2.26496487 |
| 9 | MYLK | 2.24371526 |
| 10 | RIPK1 | 2.22948440 |
| 11 | PDK4 | 2.10307349 |
| 12 | PDK3 | 2.10307349 |
| 13 | SIK1 | 2.02259870 |
| 14 | EPHA2 | 2.01013039 |
| 15 | PDGFRA | 1.94999507 |
| 16 | MAPKAPK3 | 1.92238401 |
| 17 | LATS1 | 1.71869840 |
| 18 | EPHB2 | 1.71313640 |
| 19 | TGFBR2 | 1.67725081 |
| 20 | LRRK2 | 1.64243758 |
| 21 | FER | 1.58806749 |
| 22 | LATS2 | 1.55335189 |
| 23 | CAMK1D | 1.54023889 |
| 24 | DDR2 | 1.51834320 |
| 25 | ARAF | 1.51278833 |
| 26 | PTK6 | 1.49489540 |
| 27 | NEK1 | 1.48147058 |
| 28 | SMG1 | 1.46613390 |
| 29 | PDK2 | 1.46505397 |
| 30 | PAK4 | 1.35847820 |
| 31 | MAP3K3 | 1.35506075 |
| 32 | PRKD2 | 1.33369876 |
| 33 | MST1R | 1.33034851 |
| 34 | PHKG2 | 1.32499651 |
| 35 | PHKG1 | 1.32499651 |
| 36 | EEF2K | 1.30249160 |
| 37 | DMPK | 1.29332690 |
| 38 | KDR | 1.27551035 |
| 39 | MAP2K3 | 1.26065647 |
| 40 | PTK2 | 1.23878474 |
| 41 | CDC42BPA | 1.21473361 |
| 42 | FGFR4 | 1.16436063 |
| 43 | MAP3K6 | 1.15126325 |
| 44 | NEK9 | 1.14525381 |
| 45 | MET | 1.13020983 |
| 46 | NME2 | 1.11696074 |
| 47 | EPHB1 | 1.10949289 |
| 48 | TESK1 | 1.09850329 |
| 49 | ILK | 1.09345073 |
| 50 | MAP2K1 | 1.07540281 |
| 51 | PIK3CA | 1.06873678 |
| 52 | PAK2 | 1.05147910 |
| 53 | TGFBR1 | 1.03670018 |
| 54 | FLT3 | 0.99487171 |
| 55 | LIMK1 | 0.97568922 |
| 56 | STK38L | 0.95321062 |
| 57 | TAOK2 | 0.94425757 |
| 58 | TRPM7 | 0.94157633 |
| 59 | PAK3 | 0.93667948 |
| 60 | ERBB4 | 0.93237959 |
| 61 | RET | 0.93058976 |
| 62 | WNK4 | 0.92137314 |
| 63 | BMX | 0.91156989 |
| 64 | OBSCN | 0.90366455 |
| 65 | PRPF4B | 0.85332177 |
| 66 | CAMK1G | 0.84740086 |
| 67 | TESK2 | 0.80726965 |
| 68 | MTOR | 0.79679629 |
| 69 | FRK | 0.76712273 |
| 70 | PTK2B | 0.76536570 |
| 71 | ROCK1 | 0.76096303 |
| 72 | KSR2 | 0.75604110 |
| 73 | PRKD1 | 0.75557842 |
| 74 | PRKG2 | 0.75070673 |
| 75 | RPS6KB2 | 0.74903342 |
| 76 | MAP2K2 | 0.73396510 |
| 77 | MUSK | 0.71022881 |
| 78 | NTRK1 | 0.64512401 |
| 79 | MAP3K2 | 0.64194243 |
| 80 | PIK3CG | 0.61499749 |
| 81 | CDK6 | 0.60973142 |
| 82 | ZAP70 | 0.60338495 |
| 83 | EPHA3 | 0.59929575 |
| 84 | PIM2 | 0.59127853 |
| 85 | PRKAA2 | 0.58419953 |
| 86 | PRKD3 | 0.58074009 |
| 87 | SCYL2 | 0.57682617 |
| 88 | PDGFRB | 0.57550683 |
| 89 | FGFR1 | 0.56114282 |
| 90 | DAPK3 | 0.55049339 |
| 91 | MAP3K13 | 0.52567971 |
| 92 | MAP3K11 | 0.52070050 |
| 93 | BRAF | 0.50139438 |
| 94 | MAP3K7 | 0.49959523 |
| 95 | RPS6KC1 | 0.49588311 |
| 96 | RPS6KL1 | 0.49588311 |
| 97 | STK10 | 0.49456929 |
| 98 | CAMK2G | 0.49208664 |
| 99 | FGFR3 | 0.48785858 |
| 100 | STK3 | 0.47931148 |
| 101 | CDK8 | 0.46521900 |
| 102 | PAK1 | 0.45952103 |
| 103 | ADRBK1 | 0.45676561 |
| 104 | RPS6KA6 | 0.43818481 |
| 105 | GSK3A | 0.42363624 |
| 106 | ICK | 0.41531359 |
| 107 | MAP3K8 | 0.41374963 |
| 108 | PRKAA1 | 0.38768952 |
| 109 | MARK2 | 0.38474557 |
| 110 | PDPK1 | 0.38284483 |
| 111 | DYRK1B | 0.36961124 |
| 112 | MAPKAPK2 | 0.36953794 |
| 113 | STK38 | 0.36462449 |
| 114 | ROCK2 | 0.35461502 |
| 115 | MAP3K10 | 0.35368075 |
| 116 | TAOK1 | 0.34231524 |
| 117 | MAP3K1 | 0.34002161 |
| 118 | ABL2 | 0.32991424 |
| 119 | MOS | 0.31722271 |
| 120 | TBK1 | 0.31215240 |
| 121 | MATK | 0.31038972 |
| 122 | SRC | 0.30642166 |
| 123 | MAPK12 | 0.30520849 |
| 124 | RPS6KA2 | 0.29073193 |
| 125 | MAPK15 | 0.27719372 |
| 126 | PRKCI | 0.27274379 |
| 127 | CAMK2D | 0.26912157 |
| 128 | MAPK11 | 0.26883003 |
| 129 | AKT2 | 0.22713870 |
| 130 | HIPK2 | 0.21927748 |
| 131 | CAMK2B | 0.21721230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.91562464 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.25600747 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.90641584 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.83992675 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67117233 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.51009242 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.49104355 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46802059 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.17215153 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.03129333 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.89066555 |
| 12 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.86955319 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.86892056 |
| 14 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.80873938 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.74430739 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.73482494 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73120433 |
| 18 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.71944733 |
| 19 | Focal adhesion_Homo sapiens_hsa04510 | 1.71331532 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.70153096 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.46516784 |
| 22 | Prion diseases_Homo sapiens_hsa05020 | 1.34620635 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34192970 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32539999 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.30417073 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30211503 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.28194540 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.26658141 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26345203 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26334605 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25775350 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21152129 |
| 33 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19454783 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.17133894 |
| 35 | Amoebiasis_Homo sapiens_hsa05146 | 1.17053100 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.16968778 |
| 37 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.16481658 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16264878 |
| 39 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15089070 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13083497 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.12172607 |
| 42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10001730 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 1.09220714 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08452445 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05305463 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04048131 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03873614 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03619813 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99991410 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99917671 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.99367726 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.98863725 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97650573 |
| 54 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96017337 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95315407 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 0.95266038 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.95219029 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.92521719 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 0.89575103 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89535293 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87126006 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87082403 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.85989103 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80964304 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78210619 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76832330 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76809681 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76020745 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75399600 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.73276188 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.73259769 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.72497159 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71888131 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71152477 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70530804 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68226211 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68127882 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67899666 |
| 79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66950143 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66282929 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.66116026 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65857711 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65841923 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65372322 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64903034 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.62809009 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62756190 |
| 88 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62525992 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.62113170 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61188092 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61164815 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59450361 |
| 93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58076422 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58029385 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56466220 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56176814 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54844089 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54716410 |
| 99 | Gap junction_Homo sapiens_hsa04540 | 0.54655342 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54536091 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54285526 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54273096 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54259041 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.54213620 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.53891253 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53376520 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52729834 |
| 108 | Melanogenesis_Homo sapiens_hsa04916 | 0.52602821 |
| 109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52551764 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.50627968 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50127321 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49975951 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49194244 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48842257 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48763576 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48401041 |
| 117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48057573 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47835501 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45535223 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45437532 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43401226 |
| 122 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43241015 |
| 123 | Melanoma_Homo sapiens_hsa05218 | 0.42655015 |
| 124 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42599902 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.42306171 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38552881 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.36305945 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34585330 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34505469 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33318456 |
| 131 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32737857 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.32621944 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32506690 |
| 134 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32304540 |
| 135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32184696 |
| 136 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31889416 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30529381 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30416863 |

